Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AEZS-129
AEZS-129
Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Medical News Today
Sat, 11/20/10 - 01:17 pm
Aeterna Zentaris
AEZS-129
AEZS-132
cancer
melanoma
lung cancer
prostate cancer
colon cancer
breast cancer
endometrial cancer